Showing 131-140 of 3286 results for "".
- Non-Light-Based Energy Devices Continue to Expand the Aesthetic Treatment Landscapehttps://modernaesthetics.com/news/non-light-based-energy-devices-continue-to-expand-the-aesthetic-treatment-landscape/2487934/A growing body of evidence supports the use of non-light-based energy devices as minimally invasive treatment options for a wide range of aesthetic concerns, according to a newly published review in the Journal of Craniofacial Surgery. The review summarizes current evidence surrounding r
- Swiss Skincare Brand Launches Personalized Art of Longevity Programhttps://modernaesthetics.com/news/swiss-skincare-brand-launches-personalized-art-of-longevity-program/2487890/Swiss skincare company Valmont has introduced The Art of Longevity, a personalized program designed to integrate genetic analysis, lifestyle assessment, and professional skincare into an individualized longevity strategy. According to the company, the initiative was developed by Valmont CE
- Merz Aesthetics Brings Back Original NEOCUTIS Journée Formulahttps://modernaesthetics.com/news/merz-aesthetics-brings-back-original-neocutis-journee-formula/2487865/Merz Aesthetics has reintroduced NEOCUTIS Journée Revitalizing Day Cream SPF 30, bringing back the original formulation of the company's multifunctional daytime moisturizer after previously discontinuing the Journée Firm line. According to the company, the product returns in response to fe
- Allergan Aesthetics Invests in SkinMedica's Regenerative Science Strategyhttps://modernaesthetics.com/news/allergan-aesthetics-invests-in-skinmedicas-regenerative-science-strategy/2487856/Allergan Aesthetics, an AbbVie company, announced a series of initiatives aimed at expanding SkinMedica's regenerative science platform, including the formation of a Regenerative Science Advisory Board, the expansion of its research and development laboratory, and the launch of physician-based fl
- American Pharmacists Association Urges FDA to Put Patient Safety First in Peptide Reviewhttps://modernaesthetics.com/news/apha-urges-fda-to-put-patient-safety-first-in-peptide-review/2487836/The American Pharmacists Association (APhA) is urging the US Food and Drug Administration (FDA) to prioritize patient safety, scientific evidence, and regulatory oversight in its decision-making process, according to
- Study Links Non-Ablative Fractional Laser Treatment to Epigenetic Remodeling of Aging Skinhttps://modernaesthetics.com/news/study-links-non-ablative-fractional-laser-treatment-to-epigenetic-remodeling-of-aging-skin/2487808/A new study published in Scientific Reports provides in vivo human evidence that treatment with a 1940-nm non-ablative fractional laser may induce durable epigenetic changes associated with skin rejuvenation, expanding understanding of the biologic effects of energy-based devices beyond
- MRP Signs Exclusive US Distribution Agreement to Bring Vydence Medical Platforms to Markethttps://modernaesthetics.com/news/mrp-signs-exclusive-us-distribution-agreement-to-bring-vydence-medical-platforms-to-market/2487772/Medical Resource Partners (MRP) has announced an exclusive US distribution agreement with Vydence Medical, marking the Brazilian medical device manufacturer's entry into the US aesthetics market. Under the agreement, MRP will exclusively distribute 3 energy-based platforms—the Etherea MX,
- Engineered Exosomes Show Promise for Skin Antiaging, Clinical Translation Remains Challengehttps://modernaesthetics.com/news/engineered-exosomes-show-promise-for-skin-antiaging-clinical-translation-remains-challenge/2487738/Engineered exosomes are emerging as a potential next-generation regenerative therapy for skin aging, according to a new review published in the FASEB Journal. The authors describe how bioengineered extracellular vesicles may overcome several limitations associated with conventional antia
- Wedding Milestones Continue to Drive Early Demand for Aesthetic Procedures, AAFPRS Reportshttps://modernaesthetics.com/news/wedding-milestones-continue-to-drive-early-demand-for-aesthetic-procedures-aafprs-reports/2487707/As weddings evolve into multi-event celebrations documented across professional photography and social media, facial plastic surgeons are reporting that patients are planning aesthetic treatments earlier than ever, according to the latest annual member survey from the American Academy of Facial P
- Health Canada Approves First Botulinum Toxin Type E for Aesthetic Usehttps://modernaesthetics.com/news/health-canada-approves-first-botulinum-toxin-type-e-for-aesthetic-use/2487591/Health Canada has approved Boey (trenibotulinumtoxinE; Allergan Aesthetics, an AbbVie company) for the temporary improvement in the appearance of moderate-to-severe glabellar lines in adult patients, making it the first approved botulinum neurotoxin serotype E for aesthetic use and the first rapi